About 4,150,000 results
Open links in new tab
  1. Bayer confirms 2025 Group outlook, progresses on strategic priorities

    Leverkusen, November 12, 2025 – The Bayer Group remains well on track following its performance in the first nine months of the year. Speaking on Wednesday while presenting the company’s Quarterly …

  2. Bayer Layoffs Reach 12,000 in Ongoing $2.3 Billion Restructuring Plan

    Aug 7, 2025 · Key Takeaways Bayer's restructuring aims for $2.3 billion in annual savings by 2026, with significant workforce reductions. Despite layoffs, Bayer's Q2 2025 earnings showed modest growth, …

  3. Bayer CEO warns of tough 2025 as turnaround plan beds in

    3 days ago · Things will get tougher before they get better at Bayer, according to CEO Bill Anderson, as the group reports its 2024 financial results.

  4. Bayer expects more hits to 2025 earnings from lawsuits, buyouts

    Nov 12, 2025 · Germany's Bayer said on Wednesday it expected higher one-off costs this year from litigation provisions, after recent setbacks in product liability cases, and for buying out executives in …

  5. Is a turnaround under way at Bayer? - agtechnavigator.com

    Aug 6, 2025 · But overall, the company remains confident in delivering its 2025 guidance across all divisions including crop science. Bayer has slashed 12,000 full-time positions since launching a …

  6. Bayer Q2 2025 slides: Pharma drives outlook upgrade amid FX …

    Aug 6, 2025 · Bayer AG (ETR:BAYGN) (ETR:BAYN) released its Q2 2025 financial results on August 6, showing resilience in a challenging environment and prompting an upgrade to its full-year outlook. …

  7. Germany's Bayer raises 2025 outlook after strong pharma results

    Aug 1, 2025 · German pharmaceutical giant Bayer on Thursday updated its full-year guidance following a stronger-than-expected performance in its pharmaceuticals division during the first half of the year. …

  8. Bayer stock gains on increased 2025 outlook (BAYRY)

    Aug 1, 2025 · Bayer (BAYRY) stock gains as the company raises 2025 financial outlook, citing strong pharma performance. Read more here.

  9. Bayer Adjusts 2025 Sales Forecast and Increases US Litigation Provisions

    Jul 31, 2025 · Financial Update Bayer has revised its 2025 financial guidance, projecting Group sales of €46 to €48 billion and EBITDA before special items of €9.7 to €10.2 billion. The company expects …

  10. Bayer Raises 2025 Outlook, Adds U.S. Litigation Provisions

    Aug 1, 2025 · The company has confirmed that the potential financial ramifications of such developments have been incorporated into its revised guidance. Preliminary Q2 2025 Business …